Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06875622 · ClinicalTrials.gov registry record · NA
Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
A NA study of Obesity/Therapy, sponsored by The Miriam Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 490
- Enrollment target
- 1
- Study location
NCT06875622: Recruiting NA study of Obesity/Therapy, sponsored by The Miriam Hospital.
NCT06875622 is a NA study of Obesity/Therapy that is actively recruiting participants, run by The Miriam Hospital. The registered enrollment target is 490 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06875622, a NA study of Obesity/Therapy, is actively recruiting participants, sponsored by The Miriam Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 490 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to compare two delivery formats for weight loss (automated online program vs. group-based videoconference program) and to examine the added effect of individual coaching (vs. no coaching) for individuals with overweight or obesity. All participants enrolled in this study will receive a 12-month behavioral weight loss program (varying in delivery format and individual support), and will be provided with weight loss, calorie intake, and exercise goals. Assessments will occur at baseline, 6 (mid-treatment), 12 (post-treatment), and 18 months (following 6 months of no intervention). We will also seek to determine which combination of intervention approaches works best for whom and develop algorithms which can be used to refer patients into remote programs in clinical settings or future trials.
Primary Outcome
Weight change will be assessed via smart scales using weight at baseline and 12 months and calculated as follows: (\[12-month weight minus baseline weight\] / baseline weight \* 100).
Conditions Studied
Interventions
- BEHAVIORAL Automated online weight loss program
- BEHAVIORAL Individual coaching
- BEHAVIORAL Group-based, videoconference-delivered weight loss
Study Locations (1)
Rhode Island
- The Miriam Hospital's Weight Control and Diabetes Research Center - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2025-03-03 |
| Est. Completion | 2028-10-31 |
| Phase | NA |
What NCT06875622 shows while recruiting
NCT06875622 is an interventional study that assigns participants to a tested intervention. The registered 490 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Obesity/Therapy appearing as the primary indexed condition, and to 3 interventions - of which Automated online weight loss program is the first listed.
NCT06875622 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06875622 about?
NCT06875622 is a clinical study titled "Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)". The purpose of this trial is to compare two delivery formats for weight loss (automated online program vs. group-based videoconference program) and to examine the added effect of individual coaching (vs. no coaching) for individuals with overweight or obesity. All participants enrolled in this study...
What is the current status of trial NCT06875622?
This trial is currently recruiting. It is a NA study. The enrollment target is 490 participants. The study started on 2025-03-03. Estimated completion is 2028-10-31.
What conditions does trial NCT06875622 study?
This clinical trial studies the following conditions: Obesity/Therapy.
What interventions are being tested in trial NCT06875622?
The interventions under investigation include: Automated online weight loss program (BEHAVIORAL), Individual coaching (BEHAVIORAL), Group-based, videoconference-delivered weight loss (BEHAVIORAL).
Who is sponsoring clinical trial NCT06875622?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06875622 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity/Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06875622's enrollment target sits among peer trials
490 215th of 2000 higher than 1,786 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04728893 · 490 participants · Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- NCT06238479 · 490 participants · Phase 1
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- NCT06336928 · 490 participants
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
- NCT06641414 · 490 participants · Phase 3
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI